Correction to: Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance (Cancer Science, (2012), 103, 6, (1136-1144), 10.1111/j.1349-7006.2012.02243.x);Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance

Cancer Science

Volumn 103, Issue 6, 2012, Pages 1136-1144

  Tsai, Ming Ming ^a,b   Lin, Paul Y ^c   Cheng, Wan Li ^a   Tsai, Chung Ying ^a   Chi, Hsiang Cheng ^a   Chen, Cheng Yi ^a   Tseng, Yi Hsin ^a   Cheng, Yi Fen ^a   Chen, Chi De ^a   Liang, Ying ^a   Liao, Chia Jung ^a   Wu, Sheng Ming ^a   Lin, Yang Hsiang ^a   Chung, I Hsiao ^a   Wang, Chia Siu ^c   Lin, Kwang Huei ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROSA; STOMACH CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TOTAL STOMACH RESECTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

EID: 84861683705     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.13195     Document Type: Erratum

References (42)

1. Wang CS, Hsieh CC, Chao TC et al. Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J 2002; 25: 216-27.
2. Marrelli D, Roviello F, De Stefano A et al. Prognostic significance of CEA, CA 19-9 and CA 72-4 preoperative serum levels in gastric carcinoma. Oncology 1999; 57: 55-62.
3. Lauren P. Histogenesis of intestinal and diffuse types of gastric carcinoma. Scand J Gastroenterol Suppl 1991; 180: 160-4.
4. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 265-72.
5. Cervantes A, Rodriguez Braun E, Perez Fidalgo A, Chirivella Gonzalez I. Molecular biology of gastric cancer. Clin Transl Oncol 2007; 9: 208-15.
6. Barreto-Zuniga R, Maruyama M, Kato Y et al. Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies. J Gastroenterol 1997; 32: 289-94.
7. Kim KM, Kwon MS, Hong SJ et al. Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch 2003a; 443: 491-500.
8. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer 2001; 4: 113-21.
9. Allgayer H, Heiss MM, Schildberg FW. Prognostic factors in gastric cancer. Br J Surg 1997; 84: 1651-64.
10. Chen J, Kahne T, Rocken C et al. Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 2004; 3: 1009-16.
11. Nishigaki R, Osaki M, Hiratsuka M et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 2005; 5: 3205-13.
12. Yim EK, Park JS. Role of proteomics in translational research in cervical cancer. Expert Rev Proteomics 2006; 3: 21-36.
13. Hassa PO, Haenni SS, Elser M, Hottiger MO. Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 2006; 70: 789-829.
14. D'Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006; 7: 347-58.
15. Morishige M, Hashimoto S, Ogawa E et al. GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. Nat Cell Biol 2008; 10: 85-92.
16. Muralidharan-Chari V, Hoover H, Clancy J et al. ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo. Cancer Res 2009; 69: 2201-9.
17. Hu B, Shi B, Jarzynka MJ, Yiin JJ, D'Souza-Schorey C, Cheng SY. ADP-ribosylation factor 6 regulates glioma cell invasion through the IQ-domain GTPase-activating protein 1-Rac1-mediated pathway. Cancer Res 2009; 69: 794-801.
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition. Gastric Cancer 1998; 1: 10-24.
19. Sobin LH, Fleming ID. TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-4.
20. Chen CD, Wang CS, Huang YH et al. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 2007; 7: 155-67.
21. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-8.
22. Cheng WL, Wang CS, Huang YH et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 2008; 123: 1787-96.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
24. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
25. Repesh LA. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 1989; 9: 192-208.
26. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer 2004; 91: 1924-30.
27. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 2006; 208: 633-42.
28. Yashiro M, Sunami T, Hirakawa K. CD54 expression is predictive for lymphatic spread in human gastric carcinoma. Dig Dis Sci 2005; 50: 2224-30.
29. Yamamoto S, Tomita Y, Hoshida Y et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 2006; 12: 117-22.
30. Juttner S, Wissmann C, Jons T et al. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 2006; 24: 228-40.
31. Aung PP, Oue N, Mitani Y et al. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 2005; 25: 2546-57.
32. Cheng WL, Wang CS, Huang YH, Tsai MM, Liang Y, Lin KH. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Ann Oncol 2011; 22: 2267-76.
33. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8: 86-94.
34. Kim SW, Hayashi M, Lo JF, Yang Y, Yoo JS, Lee JD. ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation. J Biol Chem 2003b; 278: 2661-8.
35. Moss J, Vaughan M. Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes. J Biol Chem 1995; 270: 12327-30.
36. Boulay PL, Schlienger S, Lewis-Saravalli S, Vitale N, Ferbeyre G, Claing A. ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein. Oncogene 2011; 30: 3846-61.
37. Boulay PL, Cotton M, Melancon P, Claing A. ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells. J Biol Chem 2008; 283: 36425-34.
38. Kon S, Tanabe K, Watanabe T, Sabe H, Satake M. Clathrin dependent endocytosis of E-cadherin is regulated by the Arf6GAP isoform SMAP1. Exp Cell Res 2008; 314: 1415-28.
39. Jang SY, Jang SW, Ko J. Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration. Cancer Lett 2012; 314: 185-97.
40. Ebert MP, Kruger S, Fogeron ML et al. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 2005; 5: 1693-704.
41. Tseng CW, Yang JC, Chen CN et al. Identification of 14-3-3beta in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics 2011; 11: 2423-39.
42. Akai T, Nabeya Y, Yahiro K et al. Helicobacter pylori induces mono-(adenosine 5′-diphosphate)-ribosylation in human gastric adenocarcinoma. Int J Oncol 2006; 29: 965-72.